Evidence map›Paper›PMID 39529799›Full record

ArticleFrontiers in medicine2024

The effects of tranexamic acid on the histopathology of defect healing in an

Anton Bermont, Shay Matalon, Daniel L Cohen, Vered Richter, Yariv Siman-Tov, Haim Shirin, Sergei Vosko

Abstract read
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anton BermontGastroenterology and Liver Diseases Institute, Shamir Medical Center, Zerifin, Israel.
Shay MatalonGastroenterology and Liver Diseases Institute, Shamir Medical Center, Zerifin, Israel.
Daniel L CohenGastroenterology and Liver Diseases Institute, Shamir Medical Center, Zerifin, Israel.
Vered RichterGastroenterology and Liver Diseases Institute, Shamir Medical Center, Zerifin, Israel.
Yariv Siman-TovPre Clinical Department, Shamir Medical Center, Zerifin, Israel.
Haim ShirinGastroenterology and Liver Diseases Institute, Shamir Medical Center, Zerifin, Israel.
Sergei VoskoGastroenterology and Liver Diseases Institute, Shamir Medical Center, Zerifin, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: There is limited data on the histopathological effects of hemostatic agents (HAs) used during endoscopic submucosal dissection (ESD). We used an Methods: Standard ESD, using a 2 mm flash-knife, was performed in three pigs. Four resections were performed in the stomach and rectum of each pig. Injectate contained 4% succinylated gelatin solution and indigo carmine, plus either TXA, adrenaline, or neither. Pigs were euthanized after 7 days and evaluated by two blinded pathologists. Results: Twenty-four defects were analyzed. Within each animal no significant histopathological changes were noted between the defects, but differences were noted between the animals. In the stomachs of the TXA and adrenaline pigs, pathology revealed a clear ulcer in the mucosa/submucosa with abundant granulation tissue, while the muscular layer was unaffected. In the control pig's stomach, the lesions were deeper, transmurally distributed, with inflammation of the muscular and adventitia layers accompanied by severe inflammation and necrosis. Fewer differences were noted in the rectum. Conclusion: For ESD, HAs such as TXA and adrenaline may have protective effects on the depth and extent of injury to the underlying tissue.

Indexed as

bleedingcomplicationsendoscopic submucosal dissectionendoscopytranexamic acid

Identifiers

PMID39529799
PMCPMC11550927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.